Finzati - Logo
AZN logo

AstraZeneca PLC

AZN • Drug Manufacturers - General
$162.70
▼ -2.07 (-1.26%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$253.97B
Growth
3.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.5%Positive revenue growth · 9.5%Positive free cash flow · 7.59Consistent free cash flow · 5/5Manageable debt level · 0.61
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 29, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$162.70
Change-1.26%
Shares Out1.56B
Market Cap$253.97B
Enterprise Value$278.33B
52W Range137.22 - 212.71
Beta0.21
P/E24.45
P/S4.20
P/B5.37
P/FCF22.85
EV/Sales4.61

Investment DNA

How strong this company looks for long-term investors

82
out of 100
Business Quality
Margins, moat, returns
88/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
94/100
Price Attractiveness
Cheap or expensive today
60/100
Why this score▼
Stable or improving margins · 17.5%Positive revenue growth · 9.5%Positive free cash flow · 7.59Consistent free cash flow · 5/5Manageable debt level · 0.61Weak liquidity · 0.94

Analyst view

Analyst sentiment and price target

AZN
Analyst sentiment
Based on 41 analyst votes · 2026-09-05
67/100
Neutral
Bullish
20
Hold
15
Bearish
6
Price Target
2026-07-02
Low
$158.00
Mean
$186.67
Median
$185.00
High
$216.00

Company Overview

IPO: 5/12/1993
Industry: Drug Manufacturers - General
P/B i: 5.37
Debt / Equity i: 0.61
Operating Margin: 23.40%
Net Margin: 17.46%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.61
Current Ratio: 0.94
Quick Ratio: 0.72
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Sharma Mani
Transaction: 06/08/2026
BUY
Change
+1
Price
$179.75
Filing
06/16/2026
Type
BUY
Sharma Mani
Transaction: 05/20/2026
SELL
Change
-11,893
Price
$185.78
Filing
05/22/2026
Type
SELL
Sharma Mani
Transaction: 05/06/2026
BUY
Change
+1
Price
$186.28
Filing
05/08/2026
Type
BUY